Anti-IgM-Mediated B Cell Signaling. Molecular Analysis of Ligand Binding Requisites for Human B Cell Clonal Expansion and Tolerance

Journal of Experimental Medicine - United States
doi 10.1084/jem.168.1.247
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Rockefeller University Press

Related search

Obinutuzumab, a Potent Anti–B-Cell Agent, for Rituximab-Unresponsive IgM Anti-Mag Neuropathy

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2018English

Hyper IgM Syndrome Associated With Defective CD40-mediated B Cell Activation.

Journal of Clinical Investigation
Medicine
1994English

Intact Active Bone Transplantation Synergizes With Anti-Cd40 Ligand Therapy to Induce B Cell Tolerance

Journal of Immunology
AllergyImmunology
2002English

Actin-Mediated Feedback Loops in B-Cell Receptor Signaling

Immunological Reviews
AllergyImmunology
2013English

Signaling Pathways for B Cell-Activating Factor (BAFF) and a Proliferation-Inducing Ligand (APRIL) in Human Placenta

American Journal of Pathology
Forensic MedicinePathology
2008English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Evolution of Anti-Dna Autoantibodies by Somatic Hypermutation: Evidence for Postmutational B Cell Tolerance

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2012English

B-Cell-Intrinsic Type 1 Interferon Signaling Is Crucial for Loss of Tolerance and the Development of Autoreactive B Cells

Cell Reports
BiochemistryGeneticsMolecular Biology
2018English

Terminating B Cell Receptor Signaling

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy